Does RITUXIMAB-ABBS Cause Diffuse large b-cell lymphoma recurrent? 18 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with RITUXIMAB-ABBS. This represents 0.4% of all adverse event reports for RITUXIMAB-ABBS.
18
Reports of Diffuse large b-cell lymphoma recurrent with RITUXIMAB-ABBS
0.4%
of all RITUXIMAB-ABBS reports
13
Deaths
2
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From RITUXIMAB-ABBS?
Of the 18 reports, 13 (72.2%) resulted in death, 2 (11.1%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-ABBS Cause?
Off label use (2,167)
Intentional product use issue (273)
Dyspnoea (208)
Pain (205)
Rheumatoid arthritis (202)
Intentional dose omission (196)
Fatigue (195)
Drug ineffective (186)
Hypertension (183)
Infusion related reaction (183)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which RITUXIMAB-ABBS Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
RITUXIMAB-ABBS vs RITUXIMAB-ARRX
RITUXIMAB-ABBS vs RITUXIMAB-PVVR
RITUXIMAB-ABBS vs RIVAROXABAN
RITUXIMAB-ABBS vs RIVASTIGMINE
RITUXIMAB-ABBS vs RIVOTRIL